Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · Real-Time Price · USD
4.850
+0.250 (5.43%)
At close: Nov 22, 2024, 4:00 PM
4.840
-0.010 (-0.21%)
After-hours: Nov 22, 2024, 7:57 PM EST
Verve Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -197.03 | -200.07 | -157.39 | -120.31 | -45.7 | -19.3 |
| Depreciation & Amortization | 6.57 | 5.46 | 2.8 | 1.54 | 1.33 | 0.11 |
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 2.78 |
| Loss (Gain) From Sale of Investments | -13.59 | -14.38 | -1.03 | 1.51 | 0.38 | -0.07 |
| Stock-Based Compensation | 42.06 | 35.12 | 22.48 | 7.07 | 0.85 | 0.45 |
| Other Operating Activities | 6.09 | 6.63 | 2.42 | 35.23 | 5.24 | 5.93 |
| Change in Accounts Receivable | 0.49 | -5.89 | -1.01 | - | - | - |
| Change in Accounts Payable | 2.18 | 3.91 | -5.22 | 6.83 | -1.9 | 1.74 |
| Change in Unearned Revenue | 7.9 | 28.54 | 20.01 | - | - | - |
| Change in Other Net Operating Assets | -12.2 | -8.86 | -5.41 | -9.74 | 4.54 | 0.93 |
| Operating Cash Flow | -157.53 | -149.55 | -122.33 | -77.88 | -35.27 | -7.44 |
| Capital Expenditures | -4.53 | -9.28 | -13.23 | -4.36 | -3.42 | -1.86 |
| Investment in Securities | 40.97 | 36.97 | -142.72 | -234.74 | -47.7 | -10.9 |
| Investing Cash Flow | 36.44 | 27.69 | -155.96 | -239.1 | -51.13 | -12.76 |
| Short-Term Debt Issued | - | - | - | - | - | 0.02 |
| Total Debt Issued | - | - | - | - | - | 0.02 |
| Net Debt Issued (Repaid) | - | - | - | - | - | 0.02 |
| Issuance of Common Stock | 201.89 | 213.04 | 329.74 | 286.96 | 0.01 | - |
| Other Financing Activities | -0.46 | -0.46 | -0.78 | -3.63 | - | -0.11 |
| Financing Cash Flow | 201.43 | 212.58 | 328.96 | 377.09 | 92.63 | 17.95 |
| Net Cash Flow | 80.34 | 90.72 | 50.67 | 60.11 | 6.24 | -2.25 |
| Free Cash Flow | -162.06 | -158.83 | -135.56 | -82.24 | -38.69 | -9.3 |
| Free Cash Flow Margin | -664.29% | -1350.84% | -6984.23% | - | - | - |
| Free Cash Flow Per Share | -2.01 | -2.47 | -2.51 | -3.06 | -17.19 | -7.28 |
| Levered Free Cash Flow | -93.18 | -110.19 | -90.05 | -42.25 | -24.46 | - |
| Unlevered Free Cash Flow | -93.18 | -110.19 | -90.05 | -42.25 | -24.46 | - |
| Change in Net Working Capital | -4.31 | 2.03 | -1.46 | -7.92 | -2.18 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.